by Syner-G | Apr 7, 2023 | Press Releases
Bringing Depth and Breadth of Biotech Experience to Oversee Continued Growth BOSTON (PRWEB) APRIL 06, 2023 – Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...
by Frank Sorce | Jan 19, 2023 | Press Releases
Expands Expertise in Biologics and Builds Scale in CMC and Quality Consulting Boston, MA, January 19, 2023 – Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...
by Frank Sorce | Jan 12, 2023 | Press Releases
Rapid Growth Drives the Need for an Investment in Talent January 10, 2023, Boston, MA — Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to the pharmaceutical and medical device...
by Frank Sorce | Jun 13, 2022 | Press Releases
RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Mr. Kraus has...
by Frank Sorce | Mar 2, 2022 | Press Releases
RESEARCH TRIANGLE PARK, NC: 01 March 2022 – In the second half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. We continued our charitable and community outreach...
by Frank Sorce | Feb 1, 2022 | Press Releases
Boston, MA (February 1, 2022) – Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls (“CMC”) technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology...